Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Xiurong Wen"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundCombining epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with chemotherapy (ETC) offers more advantages for patients with EGFR-positive non-small cell lung cancer (NSCLC) than using EGFR TKIs alone (ET). However,
Externí odkaz:
https://doaj.org/article/e976848de8d04dcfb30faf931292f757
